Page last updated: 2024-08-23

phenyl acetate and Bone Diseases, Metabolic

phenyl acetate has been researched along with Bone Diseases, Metabolic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, X; Liu, X; Liu, Z; Ma, W; Su, G; Wu, Y; Xu, Y; Yang, Q; Zhang, L; Zou, C1
Khan, DA; Khan, FA; Saif, I1
Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; Dos Reis, LM; Draibe, SA; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB1
Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V1

Reviews

2 review(s) available for phenyl acetate and Bone Diseases, Metabolic

ArticleYear
Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
    The Cochrane database of systematic reviews, 2015, Sep-16, Issue:9

    Topics: Acetates; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Bread; Calcium; Calcium Compounds; Calcium Phosphates; Calcium, Dietary; Dietary Proteins; Fibroblast Growth Factor-23; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic

2015
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8

    Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer

2006

Trials

1 trial(s) available for phenyl acetate and Bone Diseases, Metabolic

ArticleYear
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
    Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:2

    Topics: Acetates; Adult; Biomarkers; Bone Diseases, Metabolic; Calcium Compounds; Chelating Agents; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Sevelamer; Time Factors; Treatment Outcome

2010

Other Studies

1 other study(ies) available for phenyl acetate and Bone Diseases, Metabolic

ArticleYear
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
    JPMA. The Journal of the Pakistan Medical Association, 2009, Volume: 59, Issue:2

    Topics: Acetates; Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Calcium Compounds; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Renal Dialysis

2009